Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

IMPDH inhibitor VX-497 advances to clinical trials

Jan. 14, 1998

No Comments

OrthoLogic makes equity investment in Chrysalis; acquires rights to new peptide

Jan. 13, 1998

No Comments

Cellegy acquires Anogesic

Jan. 13, 1998

No Comments

ADCON-L submitted to regulatory authorities

Jan. 9, 1998

No Comments

ABX-IL-8 slated to enter clinical testing

Jan. 8, 1998

No Comments

NDA filed for betamethasone mousse

Jan. 7, 1998

No Comments

Biomatrix's Hyalform approved in additional markets; PMA resubmission planned in U.S.

Jan. 5, 1998

No Comments

Structurally distinct vitamin D analogues from Leo

Jan. 5, 1998

No Comments

FDA clears new oral treatment for hair loss in men

Dec. 29, 1997

No Comments

Apligraf scheduled for FDA advisory panel review

Dec. 24, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

BioWorld Science, Dermatologic
RSS

IMPDH inhibitor VX-497 advances to clinical trials

OrthoLogic makes equity investment in Chrysalis; acquires rights to new peptide

Cellegy acquires Anogesic

ADCON-L submitted to regulatory authorities

ABX-IL-8 slated to enter clinical testing

NDA filed for betamethasone mousse

Biomatrix's Hyalform approved in additional markets; PMA resubmission planned in U.S.

Structurally distinct vitamin D analogues from Leo

FDA clears new oral treatment for hair loss in men

Apligraf scheduled for FDA advisory panel review

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

AI drives financings, approvals for APAC med-tech in 2024

BioWorld Science, Dermatologic RSS

BioWorld Science, Dermatologic
RSS